AcuTrials

Efficacy of Acupuncture versus Local Methylprednisolone Acetate Injection in De Quervain's Tenosynovitis: A Randomized Controlled Trial

Item

Title

Efficacy of Acupuncture versus Local Methylprednisolone Acetate Injection in De Quervain's Tenosynovitis: A Randomized Controlled Trial

Journal Publication

Journal of acupuncture and meridian studies

Date

2014

volume

7(3)

pages

115-121

Research Type

RCT

Keywords

De Quervain Disease
Acu Versus Usual Care
TCM Acupuncture Style
Semi-Individualized Acupuncture Protocol
Symptom Based Point Selection
Restricted Modalities, Acupuncture Only
Usual Care Control, Physical
Corticosteroid Injection
Musculoskeletal Diseases
De Quervain's Tenosynovitis
Tendon Entrapment

Abstract

There is no consensus on the management of De Quervain's tenosynovitis, but local corticosteroid injection is considered the mainstay of treatment. However, some patients are reluctant to take steroid injections. This study was performed to compare the efficacy of acupuncture versus corticosteroid injection for the treatment of this disease. Thirty patients were consequently treated in two groups. The acupuncture group received five acupuncture sessions of 30 minutes duration on classic points of LI-5, LU-7, and LU-9 and on ahshi points. The injection group received one methylprednisolone acetate injection in the first dorsal compartment of the wrist. The degree of disability and pain was evaluated by using the Quick Disabilities of the Arm, Shoulder, and Hand (Q-DASH) scale and the Visual Analogue Scale (VAS) at baseline and at 2 weeks and 6 weeks after the start of treatment. The baseline means of the Q-DASH and the VAS scores were 62.8 and 6.9, respectively. At the last follow-up, the mean Q-DASH scores were 9.8 versus 6.2 in the acupuncture and injection groups, respectively, and the mean VAS scores were 2 versus 1.2. We demonstrated short-term improvement of pain and function in both groups. Although the success rate was somewhat higher with corticosteroid injection, acupuncture can be considered as an alternative option for treatment of De Quervain's tenosynovitis.

doi

10.1016/j.jams.2013.10.003

Frequency of Treatment

>1/WK

Time in Treatment

1 Week

has health condition studied

Pain

has study population number

35

Item sets